Leila J Mady1, Hannah L Schwarzbach2, John A Moore1, Robert M Boudreau3, Thomas M Kaffenberger1, Thomas J Willson4, Stella E Lee1. 1. Department of Otolaryngology, University of Pittsburgh, Pittsburgh, PA. 2. University of Pittsburgh School of Medicine, Pittsburgh, PA. 3. Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA. 4. Department of Otolaryngology, San Antonio Military Medical Center, Uniformed Services University of the Health Sciences, San Antonio, TX.
Abstract
BACKGROUND: There has been little investigation regarding air quality and rhinitis in the pathophysiology of upper airway disease. In this study, we assessed the impact of inhalant pollutants (particulate matter 2.5 [PM2.5 ] and black carbon [BC]) on allergic rhinitis and chronic rhinosinusitis (CRS) disease severity. METHODS: CRS patients with nasal polyps (CRSwNP) and without polyps (CRSsNP) were identified. Spatial modeling from pollutant monitoring sites was used to estimate exposures for patients meeting the inclusion criteria (total, n = 125; CRSsNP, n = 67; CRSsNP, n = 58). Skin-prick, intradermal dilutional, and in-vitro testing methods were utilized to determine aeroallergen sensitization. Disease severity indicators were measured by modified Lund-Mackay score (LMS), the 22-item Sino-Nasal Outcome Test (SNOT-22), systemic steroid therapy, and number of functional endoscopic sinus surgeries (FESS). RESULTS: Thirty-six percent (n = 45) of patients who described rhinitis symptoms demonstrated no reactivity to aeroallergen testing. Sixty-four percent (n = 80) tested positive for at least 1 allergen, with no differences found between CRSsNP and CRSwNP (62.1% vs 67.2%). There were significant differences in air pollutants between patients testing negative and positive for allergies (nonallergic vs allergic: PM2.5 , 11.32 vs 11.07 μg/m3 , p = 0.030; BC, 0.81 vs 0.76 absorbance, p =0.044). Nonallergic CRSwNP demonstrated higher PM2.5 compared with allergic counterparts (11.48 vs 11.09 μg/m3 , p = 0.032). A similar pattern was observed with BC (0.82 vs 0.75 absorbance, p = 0.017). In CRSsNP, BC correlated significantly with SNOT-22 (r = 0.55, p = 0.042). CONCLUSION: Our results suggest that small inhalant pollutants may contribute to nonallergic symptomatology in patients with and without nasal polyps. Regardless of allergy status, BC may play a role in CRS symptom severity.
BACKGROUND: There has been little investigation regarding air quality and rhinitis in the pathophysiology of upper airway disease. In this study, we assessed the impact of inhalant pollutants (particulate matter 2.5 [PM2.5 ] and black carbon [BC]) on allergic rhinitis and chronic rhinosinusitis (CRS) disease severity. METHODS:CRSpatients with nasal polyps (CRSwNP) and without polyps (CRSsNP) were identified. Spatial modeling from pollutant monitoring sites was used to estimate exposures for patients meeting the inclusion criteria (total, n = 125; CRSsNP, n = 67; CRSsNP, n = 58). Skin-prick, intradermal dilutional, and in-vitro testing methods were utilized to determine aeroallergen sensitization. Disease severity indicators were measured by modified Lund-Mackay score (LMS), the 22-item Sino-Nasal Outcome Test (SNOT-22), systemic steroid therapy, and number of functional endoscopic sinus surgeries (FESS). RESULTS: Thirty-six percent (n = 45) of patients who described rhinitis symptoms demonstrated no reactivity to aeroallergen testing. Sixty-four percent (n = 80) tested positive for at least 1 allergen, with no differences found between CRSsNP and CRSwNP (62.1% vs 67.2%). There were significant differences in air pollutants between patients testing negative and positive for allergies (nonallergic vs allergic: PM2.5 , 11.32 vs 11.07 μg/m3 , p = 0.030; BC, 0.81 vs 0.76 absorbance, p =0.044). Nonallergic CRSwNP demonstrated higher PM2.5 compared with allergic counterparts (11.48 vs 11.09 μg/m3 , p = 0.032). A similar pattern was observed with BC (0.82 vs 0.75 absorbance, p = 0.017). In CRSsNP, BC correlated significantly with SNOT-22 (r = 0.55, p = 0.042). CONCLUSION: Our results suggest that small inhalant pollutants may contribute to nonallergic symptomatology in patients with and without nasal polyps. Regardless of allergy status, BC may play a role in CRS symptom severity.
Authors: Ruo-Ling Li; Yung-Chyuan Ho; Ci-Wen Luo; Shiuan-Shinn Lee; Yu-Hsiang Kuan Journal: Int J Environ Res Public Health Date: 2019-09-11 Impact factor: 3.390
Authors: Massimiliano Marazzato; Anna Maria Zicari; Marta Aleandri; Antonietta Lucia Conte; Catia Longhi; Luca Vitanza; Vanessa Bolognino; Carlo Zagaglia; Giovanna De Castro; Giulia Brindisi; Laura Schiavi; Valentina De Vittori; Sofia Reddel; Andrea Quagliariello; Federica Del Chierico; Lorenza Putignani; Marzia Duse; Anna Teresa Palamara; Maria Pia Conte Journal: Front Cell Infect Microbiol Date: 2020-09-02 Impact factor: 5.293
Authors: Michael Hoggard; Sharon Waldvogel-Thurlow; Melissa Zoing; Kevin Chang; Fiona J Radcliff; Brett Wagner Mackenzie; Kristi Biswas; Richard G Douglas; Michael W Taylor Journal: Front Immunol Date: 2018-09-19 Impact factor: 7.561
Authors: Zhenyu Zhang; Nicholas R Rowan; Jayant M Pinto; Nyall R London; Andrew P Lane; Shyam Biswal; Murugappan Ramanathan Journal: JAMA Netw Open Date: 2021-05-03